Ira Duarte
2023
In 2023, Ira Duarte earned a total compensation of $1.5M as Chief Financial Officer at Heron Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $128,844 |
|---|---|
| Option Awards | $1,066,875 |
| Salary | $271,154 |
| Stock Awards | $60,500 |
| Other | $7,500 |
| Total | $1,534,873 |
Duarte received $1.1M in option awards, accounting for 70% of the total pay in 2023.
Duarte also received $128.8K in non-equity incentive plan, $271.2K in salary, $60.5K in stock awards and $7.5K in other compensation.
Rankings
In 2023, Ira Duarte's compensation ranked 773rd out of 2,990 executives tracked by ExecPay. In other words, Duarte earned more than 74.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 773 out of 2,990 | 74th |
Division Manufacturing | 447 out of 1,640 | 73rd |
Major group Chemicals And Allied Products | 306 out of 909 | 66th |
Industry group Drugs | 300 out of 872 | 66th |
Industry Pharmaceutical Preparations | 200 out of 630 | 68th |
Source: SEC filing on April 29, 2024.
Duarte's colleagues
We found four more compensation records of executives who worked with Ira Duarte at Heron Therapeutics in 2023.